Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Catch me if you can: how AML and its niche escape immunotherapy
Sarah Tettamanti, Alice Pievani, Andrea Biondi, et al.
Leukemia (2021) Vol. 36, Iss. 1, pp. 13-22
Open Access | Times Cited: 124

Showing 1-25 of 124 citing articles:

STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia
Ze-Wei Huang, Xuening Zhang, Ling Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 59
Relapse of acute myeloid leukemia after allogeneic stem cell transplantation: immune escape mechanisms and current implications for therapy
Tatjana Sauerer, Giuliano Filippini Velázquez, Christoph Schmid
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 32
Comprehensive review of histone lactylation: Structure, function, and therapeutic targets
Kaiwen Xu, Zhang Keyi, Yanshuang Wang, et al.
Biochemical Pharmacology (2024) Vol. 225, pp. 116331-116331
Closed Access | Times Cited: 11
Lactate acid promotes PD-1+ Tregs accumulation in the bone marrow with high tumor burden of Acute myeloid leukemia
Yining Zhang, Yueting Huang, Hong Yan, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111765-111765
Closed Access | Times Cited: 10
Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches
Thomas Menter, Alexandar Tzankov
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia
Jinghua Wang, Zewei Zhuo, Yanjun Wang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 28
First‐in‐human study of JNJ‐67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome
Rupa Narayan, Ana Alfonso Piérola, William B. Donnellan, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 6
ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion
Barbara Bassani, Giorgia Simonetti, Valeria Cancila, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113794-113794
Open Access | Times Cited: 5
Epigenetic control over the cell-intrinsic immune response antagonizes self-renewal in acute myeloid leukemia
E. Fumero, Carolin Walter, J. Frenz, et al.
Blood (2024) Vol. 143, Iss. 22, pp. 2284-2299
Open Access | Times Cited: 5
The critical role of the bone marrow stromal microenvironment for the development of drug screening platforms in leukemia
Rhiannon G. Panting, Rishi S. Kotecha, Laurence C. Cheung
Experimental Hematology (2024) Vol. 133, pp. 104212-104212
Open Access | Times Cited: 5
HLA-DM and HLA-DO interplay for the peptide editing of HLA class II in healthy tissues and leukemia
Bettina Budeus, Miguel Álvaro‐Benito, Pietro Crivello
Best Practice & Research Clinical Haematology (2024) Vol. 37, Iss. 2, pp. 101561-101561
Closed Access | Times Cited: 5
Polymorphisms in immunosuppression-related genes are associated with AML
Mingying Li, Jingjing Ye, Mengyuan Chang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Tubeimoside I induces mitophagy by activating the PINK1/Parkin/Mfn2 signaling pathway in acute myeloid leukemia cells
Jing Xu, Fanggang Ren, Jinjuan Wang, et al.
Translational Oncology (2025) Vol. 55, pp. 102355-102355
Closed Access
m6A-related lncRNAs predict prognosis and indicate immune microenvironment in acute myeloid leukemia
Fangmin Zhong, Fangyi Yao, Ying Cheng, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Bispecific Antibodies in Hematological Malignancies: A Scoping Review
Mohamed H. Omer, Areez Shafqat, Omar Ahmad, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4550-4550
Open Access | Times Cited: 15
Microenvironment in acute myeloid leukemia: focus on senescence mechanisms, therapeutic interactions, and future directions
Luca Guarnera, Enrico Santinelli, Elisa Galossi, et al.
Experimental Hematology (2023) Vol. 129, pp. 104118-104118
Closed Access | Times Cited: 15
Discovery of Small-Molecule TIM-3 Inhibitors for Acute Myeloid Leukemia Using Pharmacophore-Based Virtual Screening
Somaya A. Abdel‐Rahman, Valerij Talagayev, Szymon Pach, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11464-11475
Closed Access | Times Cited: 13
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Xia Wu, Fangfang Wang, Xijing Yang, et al.
Small (2024) Vol. 20, Iss. 42
Closed Access | Times Cited: 5
Immune control in acute myeloid leukemia
Jasmin Straube, Yashaswini Janardhanan, Rohit Haldar, et al.
Experimental Hematology (2024) Vol. 138, pp. 104256-104256
Open Access | Times Cited: 4
Unleashing the TLR9-driven multilineage differentiation of myeloid leukemia cells in vivo
Katarzyna Piwocka
Molecular Therapy — Nucleic Acids (2025) Vol. 36, Iss. 1, pp. 102430-102430
Open Access
Construction of a stromal-related prognostic model in acute myeloid leukemia by comprehensive bioinformatics analysis
Laya Khodayi Hajipirloo, Maryam Nabigol, Reza Khayami, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103492-103492
Closed Access
Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: A bibliometric analysis
Nana Zhe, Qiang Li, Nanqu Huang, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies
Scott D. Rowley, Maher Albitar, Melissa Baker, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 625-625
Open Access
A Novel Prognostic Risk‐Scoring Model Based on RAS Gene‐Associated Cluster in Pediatric Acute Myeloid Leukemia
Chen Luo, Yilimuguli Abudukeremu, Mingliang Rao, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
STAB1 Promotes Acute Myeloid Leukemia Progression by Activating the IKK/NF‐κB Pathway and Increasing M2 Macrophage Polarization
Jiaxiu Yin, Jing Luo, Lan Wang, et al.
Cancer Science (2025)
Open Access
Page 1 - Next Page

Scroll to top